5 ePosters
Session Name- SaaG e-Posters: Removing cholesterol: efflux and reverse cholesterol transport
Filtered By
- SaaG e-Posters: Removing cholesterol: efflux and reverse cholesterol transport
Sort By
2. LIPIDS AND LIPOPROTEINS || 2.3 HDL
184 - HDL efflux capacity, and particle remodelling in patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) (ID 1163)
Session Name
SaaG e-Posters: Removing cholesterol: efflux and reverse cholesterol transport
Presentation Topic
2.3 HDL
Presenter
2. LIPIDS AND LIPOPROTEINS || 2.6 Cholesterol efflux and reverse cholesterol transport
185 - High lysophosphatidylcholine and low phosphatidylcholine concentrations in HDL phospholipids are associated with atherosclerosis in relation to decreased cholesterol efflux capacity (ID 173)
Session Name
SaaG e-Posters: Removing cholesterol: efflux and reverse cholesterol transport
Presentation Topic
2.6 Cholesterol efflux and reverse cholesterol transport
Presenter
186 - Preβ-apoA-I in apoB-depleted human plasma is a major acceptor of BODIPY-Cholesterol effluxed from RAW 264.7 macrophages (ID 72)
Session Name
SaaG e-Posters: Removing cholesterol: efflux and reverse cholesterol transport
Presentation Topic
2.6 Cholesterol efflux and reverse cholesterol transport
187 - Effects of HDL triglyceride enrichment on reverse cholesterol transport in dyslipidemic patients (ID 894)
Session Name
SaaG e-Posters: Removing cholesterol: efflux and reverse cholesterol transport
Presentation Topic
2.6 Cholesterol efflux and reverse cholesterol transport
Presenter
188 - Modulation of cholesterol efflux capacity (CEC) of high density lipoprotein (HDL) with bariatric surgery (ID 1064)
Session Name
SaaG e-Posters: Removing cholesterol: efflux and reverse cholesterol transport
Presentation Topic
2.6 Cholesterol efflux and reverse cholesterol transport
Presenter